Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E‐mutated and microsatellite unstable metastatic colorectal cancer patient: A case report.
- Resource Type
- Article
- Source
- Genes, Chromosomes & Cancer; Feb2022, Vol. 61 Issue 2, p114-118, 5p
- Subject
- Language
- ISSN
- 10452257